Yoshihiko Kanno

Papers

Total Citations

H-Index

About

Yoshihiko Kanno is a prominent nephrologist whose research centers on the renin-angiotensin system (RAS) and its role in kidney inflammation and immune-mediated diseases. His most cited work, a 2006 study, demonstrated a possible anti-inflammatory role of the angiotensin II type 2 receptor (AT2R) during type 1 receptor blockade in immune-mediated glomerulonephritis. This finding challenged the conventional view that all angiotensin II signaling is harmful, suggesting that AT2R activation could be harnessed therapeutically to reduce renal inflammation. With over 40 citations, this paper has influenced subsequent investigations into selective AT2R agonists as novel treatments for kidney disease. Kanno’s broader contributions include elucidating the complex interplay between RAS components and immune cells in glomerular injury, paving the way for more targeted immunomodulatory strategies. His work is particularly relevant for researchers exploring the balance between pro- and anti-inflammatory pathways in nephrology, and his insights continue to shape the development of next-generation therapies for glomerulonephritis and other inflammatory kidney conditions.